Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/76675
Título: | Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer |
Autor(es): | Abreu, Catarina M. Silva, Bruno Costa Reis, R. L. Kundu, Subhas C Caballero, David |
Palavras-chave: | Cancer Exosomes Extracellular vesicles Liquid biopsy Microfluidics |
Data: | Mar-2022 |
Editora: | Royal Society of Chemistry |
Revista: | Lab on a Chip |
Citação: | Abreu C. M., Costa-Silva B., Reis R. L., Kundu S. C., Caballero D. Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer, Lab on a Chip, Vol. 22, pp. 1093-1125, doi:10.1039/D2LC00006G, 2022 |
Resumo(s): | Extracellular vesicles (EVs) are small lipidic particles packed with proteins, DNA, messenger RNA and microRNAs of their cell of origin that act as critical players in cellâ cell communication. These vesicles have been identified as pivotal mediators in cancer progression and the formation of metastatic niches. Hence, their isolation and analysis from circulating biofluids is envisioned as the next big thing in the field of liquid biopsies for early non-invasive diagnosis and patient follow-up. Despite the promise, current benchtop isolation strategies are not compatible with point-of-care testing in a clinical setting. Microfluidic platforms are disruptive technologies capable of recovering, analyzing, and quantifying EVs within clinical samples with limited volume, in a high-throughput manner with elevated sensitivity and multiplexing capabilities. Moreover, they can also be employed for the controlled production of synthetic EVs and effective drug loading to produce EV-based therapies. In this review, we explore the use of microfluidic platforms for the isolation, characterization, and quantification of EVs in cancer, and compare these platforms with the conventional methodologies. We also highlight the state-of-the-art in microfluidic approaches for EV-based cancer therapeutics. Finally, we analyze the currently active or recently completed clinical trials involving EVs for cancer diagnosis, treatment or therapy monitoring and examine the future of EV-based point-of-care testing platforms in the clinic and EV-based therapy production by the industry. |
Tipo: | Artigo |
URI: | https://hdl.handle.net/1822/76675 |
DOI: | 10.1039/D2LC00006G |
ISSN: | 1473-0189 |
Versão da editora: | https://pubs.rsc.org/en/content/articlelanding/2022/lc/d2lc00006g |
Arbitragem científica: | yes |
Acesso: | Acesso restrito UMinho |
Aparece nas coleções: | 3B’s - Artigos em revistas/Papers in scientific journals |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
20748-abreu-et-al-2022-loc-revised-manuscript-20220202.pdf Acesso restrito! | 707,35 kB | Adobe PDF | Ver/Abrir |